Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.
about
Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates.Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBMHerpes simplex virus oncolytic therapy for pediatric malignanciesEvaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates.Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in miceComplement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.Conditionally replicating herpes vectors for cancer therapy.Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiformeHerpes simplex viruses: is a vaccine tenable?Targeting pediatric cancer stem cells with oncolytic virotherapyOncolytic polio virotherapy of cancerRegulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis.Attenuation of herpes simplex virus neurovirulence with picornavirus cis-acting genetic elements.Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.Gene therapy for malignant glioma.Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapyViruses as anticancer drugs.Oncolytic herpes viruses, chemotherapeutics, and other cancer drugsRas signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpesMolecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines.Gene therapy for high-grade glioma: current approaches and future directions.Oncolytic viral therapy of malignant gliomaSpread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.The Characteristics of Herpes Simplex Virus Type 1 Infection in Rhesus Macaques and the Associated Pathological Features.Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates.HSV Recombinant Vectors for Gene Therapy.Oncolytic Virotherapy for the Treatment of Malignant Glioma.Oncolytic virotherapy: the questions and the promise.Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2.Stimulus-responsive viral vectors for controlled delivery of therapeutics.Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors.Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.Oncolytic viral therapy for human prostate cancer by conditionally replicating herpes simplex virus 1 vector G207.Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques.Attenuated Phenotype and Immunogenic Characteristics of a Mutated Herpes Simplex Virus 1 Strain in the Rhesus Macaque.
P2860
Q28210728-AA2F27E2-4F08-4C04-94C5-C2815CE64ED1Q33712977-AD2063C8-70F2-4290-B10F-30D2FDEA4818Q33713824-2A0436E3-37DC-4666-861B-33595304A322Q33720628-D71812A2-A4AF-4569-B9F8-15F055568CA9Q33799437-B614164C-6F3F-4C08-A12C-A6FFC54248F2Q33802747-EC0AC15A-13B9-4EA7-938F-1A0661CDFC96Q33804845-A8CC20ED-F0BB-40B0-81B4-B683ED8F8142Q33882697-5146D95C-34E2-4CAC-9C92-5D72DFD1A4B7Q34105106-2C731676-4607-413F-9504-54FEECAEEA73Q34139375-E84F8425-976C-4961-9408-8E052503AAEDQ34262327-195B52D5-263B-4F16-8511-782ED1EF5977Q34425385-7733FDCA-8F65-44EA-9A8C-01E2A74C8429Q34790267-4B639114-A7CF-438C-BE79-2BAE58D0F66EQ34928710-01A6A751-DDE9-494E-8A4E-0E6A5A8CB25CQ35635064-4A840923-12DA-4CBC-B7F2-B8B5B2F64974Q35649214-54ACCCAD-A032-4D39-BFEF-132267703B19Q35673628-F771AF9C-55D7-414F-B0C5-5DD8311C049EQ35943736-9C7093CA-FCE1-48B5-8D6D-91ACD36F2A5BQ35945465-F60894F4-478D-418D-8A34-6416333E0C3DQ36109704-0742E841-9768-4704-9754-30539FB54E26Q36644898-6AA9B0DD-8B50-4F86-A278-8AA380A590A9Q36850878-D8391DC8-F4F0-4BE0-9CFA-29B9989E6349Q37031896-658503A5-9D02-4D9A-BD6E-90FEBE764DE2Q37061120-73864310-89AF-40DA-8907-5A6B6E42AFB6Q37079854-4A0C5FA6-4CC5-4665-81A0-4FE5BE225F83Q37406685-732E876A-FEE7-4A47-A42E-5946F624A8F4Q37533665-CF426D04-4CB8-4F2D-B472-29B6AF2C7FD2Q37596491-802FAF53-169F-4597-94DD-A1E8CB295DACQ37676086-5B2592CF-D98B-4869-9C69-EF8091381570Q37718569-6B433B1E-06BF-418D-A3D4-B066AEE9E71BQ37787777-22123403-0FA2-4DDA-BC5C-9D09C668FBCEQ38749871-A0A50B5A-8C8B-44B5-B26D-A7F7E7B45E5CQ38924527-9DA050C1-1F9F-4211-A484-964FBF045450Q39953338-2D8FAAFF-99B8-4509-B212-FF851B4C6AA2Q40069936-C6917E2F-5972-4B1D-8695-B6E5DA25DAFAQ40284855-5D812709-C640-4E7C-896A-7A71C01EA495Q41919532-D7CEFFD1-CB1E-419A-B4B0-8ECEC235CF21Q45739297-0149F1E1-1E21-4037-9829-4C00646513CBQ47563232-FEA0BED4-DB37-46F2-AE50-D183BFD65F65Q55284064-E6979A66-5403-404C-9DF3-4DA1E9580C86
P2860
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Attenuated, replication-compet ...... njection in nonhuman primates.
@ast
Attenuated, replication-compet ...... njection in nonhuman primates.
@en
type
label
Attenuated, replication-compet ...... njection in nonhuman primates.
@ast
Attenuated, replication-compet ...... njection in nonhuman primates.
@en
prefLabel
Attenuated, replication-compet ...... njection in nonhuman primates.
@ast
Attenuated, replication-compet ...... njection in nonhuman primates.
@en
P2093
P2860
P1433
P1476
Attenuated, replication-compet ...... injection in nonhuman primates
@en
P2093
F Feigenbaum
J T Newsome
R C Platenberg
R L Martuza
S D Rabkin
P2860
P304
P577
1999-08-01T00:00:00Z